CARCINOMA, TRANSITIONAL CELL
Clinical trials for CARCINOMA, TRANSITIONAL CELL explained in plain language.
Never miss a new study
Get alerted when new CARCINOMA, TRANSITIONAL CELL trials appear
Sign up with your email to follow new studies for CARCINOMA, TRANSITIONAL CELL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Experimental drug combo shows promise for Tough-to-Treat bladder cancer
Disease control TerminatedThis study tested an experimental drug called enfortumab vedotin, alone or with other cancer drugs, in 348 people with advanced bladder or urinary tract cancer. The goal was to see if the drug could shrink tumors and control the disease. The trial was terminated early, so the ful…
Matched conditions: CARCINOMA, TRANSITIONAL CELL
Phase: PHASE1, PHASE2 • Sponsor: Astellas Pharma Global Development, Inc. • Aim: Disease control
Last updated Jun 22, 2026 11:59 UTC
-
New bladder cancer drug delivered directly into bladder shows early promise
Disease control TerminatedThis early-phase trial tested enfortumab vedotin, a drug placed directly into the bladder via a catheter, in 37 people with a type of bladder cancer that did not respond to standard BCG therapy. The main goals were to check safety and side effects, and to see if the drug could he…
Matched conditions: CARCINOMA, TRANSITIONAL CELL
Phase: PHASE1 • Sponsor: Astellas Pharma Global Development, Inc. • Aim: Disease control
Last updated Jun 22, 2026 11:56 UTC